- IN₹21.00bn
- IN₹21.24bn
- IN₹3.85bn
India's Beta Drugs jumps after regulatory milestones in Azerbaijan, Philippines
Brief: Beta Drugs Achieves Regulatory Milestones In Azerbaijan And Philippines
Brief: Beta Drugs To Buy 66.09% Of Nivian Life Sciences For 694 MLN Rupees
Brief: Beta Drugs Receives Dcgi Approval For Methotrexate Oral Solution
Brief: Beta Drugs To Consider Raising Of Funds
Brief: Beta Drugs To Write Off Investment Made Amounting $88,000 In Beta Ubk. International
Brief: Beta Drugs's Baddi Oncology Manufacturing Plant Receives ANVISA Approval
Brief: Beta Drugs Receives Drug Controller General Of India Nod To Launch Enzalutamide 160Mg